These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 12815332

  • 1. Involution of the parathyroid glands after renal transplantation.
    Lewin E.
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):363-71. PubMed ID: 12815332
    [Abstract] [Full Text] [Related]

  • 2. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
    Lewin E, Garfia B, Recio FL, Rodriguez M, Olgaard K.
    J Am Soc Nephrol; 2002 Aug; 13(8):2110-6. PubMed ID: 12138143
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Parathyroid hormone regulation in normal and uremic rats. Reversibility of secondary hyperparathyroidism after experimental kidney transplantation.
    Lewin E.
    Dan Med Bull; 2004 May; 51(2):184-206. PubMed ID: 16009056
    [No Abstract] [Full Text] [Related]

  • 5. Influence of parathyroid mass on the regulation of PTH secretion.
    Lewin E, Olgaard K.
    Kidney Int Suppl; 2006 Jul; (102):S16-21. PubMed ID: 16810305
    [Abstract] [Full Text] [Related]

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 7. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J, Martuseviciene G, Santini MA, Olgaard K, Lewin E.
    Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
    [Abstract] [Full Text] [Related]

  • 8. A model of reversible uremia employing isogenic kidney transplantation in the rat. Reversibility of secondary hyperparathyroidism.
    Lewin E, Colstrup H, Pless V, Ladefoged J, Olgaard K.
    Scand J Urol Nephrol; 1993 Dec; 27(1):115-20. PubMed ID: 8493458
    [Abstract] [Full Text] [Related]

  • 9. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E, Finch J, Ritter C, Takahashi F.
    Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [Abstract] [Full Text] [Related]

  • 10. Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.
    Massry SG, Coburn JW, Popovtzer MM, Shinaberger JH, Maxwell MH, Kleeman CR.
    Arch Intern Med; 1969 Oct; 124(4):431-41. PubMed ID: 4901739
    [No Abstract] [Full Text] [Related]

  • 11. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodríguez M, Almaden Y.
    Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid growth and suppression in renal failure.
    Lewin E, Huan J, Olgaard K.
    Semin Dial; 2006 Apr; 19(3):238-45. PubMed ID: 16689976
    [Abstract] [Full Text] [Related]

  • 13. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats.
    Lewin E, Garfia B, Almaden Y, Rodriguez M, Olgaard K.
    Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396
    [Abstract] [Full Text] [Related]

  • 14. FGF23 fails to inhibit uremic parathyroid glands.
    Canalejo R, Canalejo A, Martinez-Moreno JM, Rodriguez-Ortiz ME, Estepa JC, Mendoza FJ, Munoz-Castaneda JR, Shalhoub V, Almaden Y, Rodriguez M.
    J Am Soc Nephrol; 2010 Jul; 21(7):1125-35. PubMed ID: 20431039
    [Abstract] [Full Text] [Related]

  • 15. Persistent hyperparathyroidism in renal allograft recipients: vitamin D receptor, calcium-sensing receptor, and apoptosis.
    Taniguchi M, Tokumoto M, Matsuo D, Motoyama K, Sugitani A, Kuroki S, Yotsueda H, Tsuruya K, Hirakata H, Iida M.
    Kidney Int; 2006 Jul; 70(2):363-70. PubMed ID: 16738533
    [Abstract] [Full Text] [Related]

  • 16. Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.
    Naveh-Many T, Volovelsky O.
    Int J Mol Sci; 2020 Jun 18; 21(12):. PubMed ID: 32570711
    [Abstract] [Full Text] [Related]

  • 17. Calcium-sensing by parathyroid glands in secondary hyperparathyroidism.
    Goodman WG, Veldhuis JD, Belin TR, Van Herle AJ, Juppner H, Salusky IB.
    J Clin Endocrinol Metab; 1998 Aug 18; 83(8):2765-72. PubMed ID: 9709944
    [Abstract] [Full Text] [Related]

  • 18. A new experimental model for secondary hyperparathyroidism.
    Sancho JJ, Duh QY, Oms L, Sitges-Serra A, Hammond ME, Arnaud CD, Clark OH.
    Surgery; 1989 Dec 18; 106(6):1002-8. PubMed ID: 2588105
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients.
    Nakamura M, Tanaka K, Marui Y, Tomikawa S.
    Ther Apher Dial; 2013 Oct 18; 17(5):551-6. PubMed ID: 24107283
    [Abstract] [Full Text] [Related]

  • 20. [MIBI and parathyroid gland function in secondary hyperparathyroidism].
    Martín F, Sarró F, Verdú J, González A, Martínez F.
    Nefrologia; 2004 Oct 18; 24(4):344-50. PubMed ID: 15455494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.